The FDA Foundation Research Program works to accelerate and improve the availability of safe and effective medical products.

The Expanded Access Navigator, or EA Navigator, represents a unique partnership between the Reagan-Udall Foundation for the FDA, patient advocacy organizations, the pharmaceutical industry, and the federal government to provide clear, digestible information on single-patient EA.

Learn how the Reagan-Udall Foundation for the FDA supports strategies to prevent, treat, and manage substance use disorders by engaging stakeholders and addressing critical gaps in the SUD treatment system.

The Reagan-Udall Foundation for the FDA's work supports FDA’s advancement of the Nutrition Innovation Strategy, promotes actions to reduce preventable death and disease related to poor nutrition. The Foundation is engaging with stakeholders -- including regulators, consumers, and industry -- to further food system strategies that foster industry innovation and change in consumer behavior.